Clinical trials
Phase 2 Obesity trials in Puerto Rico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 6 |
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| AbbVie | 1 |
| Amgen | 1 |
| Aphaia Pharma US LLC | 1 |
| AstraZeneca | 1 |
| BioAge Labs, Inc. | 1 |
| Carmot Therapeutics, Inc. | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Novartis Pharmaceuticals | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 16 |
| Overweight | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Diabetes Mellitus | 3 |
| Hypertension | 3 |
| Weight Loss | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
| Endocrine System Diseases | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.